On September 18, 2023, MEI Pharma, Inc. issued a statement regarding the nomination of 3 director candidates by Anson Advisors Inc. and Cable Car Capital LLC to stand for election to the Company?s Board of Directors at MEI?s fiscal year 2024 Annual Meeting of Stockholders.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.05 USD | -1.61% | -6.15% | -47.41% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.41% | 20.32M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- MEIP Stock
- News MEI Pharma, Inc.
- MEI Pharma Confirms Receipt of Director Nominations from Anson Group